Cargando…
Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
Although clozapine has demonstrated superior efficacy in patients with schizophrenia and other serious mental health illness, drug utilization rates are significantly low due to safety concerns and administration challenges. Previous research indicates that current barriers to clozapine use include...
Autores principales: | Kalaria, Shamir N, Kelly, Deanna L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708436/ https://www.ncbi.nlm.nih.gov/pubmed/31692521 http://dx.doi.org/10.2147/NDT.S216803 |
Ejemplares similares
-
Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021) -
T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020) -
Point-of-Care Testing for Pharyngitis in the Pharmacy
por: Essack, Sabiha, et al.
Publicado: (2020) -
A Call to Action: Integration of Buprenorphine Prescribing Into the Care of Persons With Human Immunodeficiency Virus and Opioid Use Disorder
por: Fujita, A Wendy, et al.
Publicado: (2022) -
Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020)